Use of covid-19 convalescent plasma to treat patients admitted to hospital for covid-19 with or without underlying immunodeficiency: open label, randomised clinical trial

Use of covid-19 convalescent plasma to treat patients admitted to hospital for covid-19 with or without underlying immunodeficiency: open label, randomised clinical trial

Objective To evaluate the efficacy of covid-19 convalescent plasma to treat patients admitted to hospital for moderate covid-19 disease with or without underlying immunodeficiency (CORIPLASM trial).Design Open label, randomised clinical trial.Setting CORIMUNO-19 cohort (publicly supported platform o...

Full description

Saved in:
Bibliographic Details
Main Authors: Arsène Mekinian, Xavier Mariette, Florence Ader, Raphaël Porcher, Philippe Ravaud, Lionel Piroth, Gabriel Baron, Jean-Marie Michot, Karine Lacombe, Tabassome Simon, Sophie Georgin-Lavialle, Charles Cazanave, Marc Michel, Olivier Hermine, Guillaume Martin-Blondel, Fabrice Bonnet, Pierre Tiberghien, Xavier Lescure, Xavier de Lamballerie, Valérie Pourcher, Matthieu Resche-Rigon, Thibault Chiarabini, Stella Rousset, Fanny Pommeret, Thomas Hueso, Julien Saison, Nathalie De Castro, Anne Francois, Pascal Morel, Nora Soussi, Phillipe Brun, Pierre Sellier, Pierre-Louis Tharaux
Format: Article
Language:English
Published: BMJ Publishing Group 2023-10-01
Series:BMJ Medicine
Online Access:https://bmjmedicine.bmj.com/content/2/1/e000427.full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://bmjmedicine.bmj.com/content/2/1/e000427.full

Similar Items